RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kevin Williams to Harmine

Back to Details
This is a "connection" page, showing publications Kevin Williams has written about Harmine.
Kevin Williams
Connection Strength
0.405
Harmine
  1. Poje G, ?akic D, Marinovic M, You J, Tarpley M, Williams KP, Golub N, Dernov?ek J, Toma?ic T, Be?ic E, Rajic Z. Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids. Acta Pharm. 2024 Dec 01; 74(4):595-612.
    View in: PubMed
    Score: 0.228
  2. Tarpley M, Oladapo HO, Strepay D, Caligan TB, Chdid L, Shehata H, Roques JR, Thomas R, Laudeman CP, Onyenwoke RU, Darr DB, Williams KP. Identification of harmine and ?-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies. Eur J Pharm Sci. 2021 Jul 01; 162:105821.
    View in: PubMed
    Score: 0.177
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support